PAR PHARMACEUTICAL, INC. v. TWI PHARMACEUTICALS, INC. , No. 15-1880 (Fed. Cir. 2015)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ PAR PHARMACEUTICAL, INC., ALKERMES PHARMA IRELAND LIMITED, Plaintiffs-Appellants v. TWI PHARMACEUTICALS, INC., Defendant-Appellee ______________________ 2015-1880 ______________________ Appeal from the United States District Court for the District of Maryland in No. 1:11-cv-02466-CCB, Judge Catherine C. Blake. ______________________ JUDGMENT ______________________ DANIEL BROWN, Latham & Watkins LLP, New York, NY, argued for plaintiffs-appellants. Plaintiff-appellant Par Pharmaceutical, Inc., also represented by ROGER J. CHIN, GREGORY SOBOLSKI, San Francisco, CA; JONATHAN Y. ELLIS, GREGORY G. GARRE, MICHAEL J. GERARDI, Washington, DC; JAMES PATRICK ULWICK, Kramon and Graham, P.A., Baltimore, MD. MARYELLEN NOREIKA, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE, for plaintiff-appellant Alkermes Pharma Ireland Limited. Also represented by JACK B. BLUMENFELD, JEREMY A. TIGAN; JAMES PATRICK ULWICK, Kramon and Graham, P.A., Baltimore, MD. DONALD J. MIZERK, Husch Blackwell LLP, Chicago, IL, argued for defendant-appellee. Also represented by PHILIP DALE SEGREST, JR., JOHN A. SHOLAR, JR. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (O’MALLEY, PLAGER, and WALLACH, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT December 15, 2015 Date /s/ Daniel E. O’Toole Daniel E. O’Toole Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.